The prognostic impact of body mass index (BMI) in patients with upper tract urothelial carcinoma (UTUC) is an ongoing debate. Our study aimed to investigate the prognostic role of BMI in patients treated with radical nephroureterectomy (RNU) for UTUC from a multiinstitutional Korean collaboration. We retrospectively reviewed data from 440 patients who underwent RNU for UTUC at four institutions in Korea. To avoid biasing the survival estimates, patients who had previous or concomitant muscle-invasive bladder tumors were excluded. BMI was categorized into approximate quartiles with the lowest quartile assigned to the reference group. Kaplan-Meier and multivariate Cox regression analyses were performed to assess the influence of BMI on survival. The lower quartile BMI group showed significantly increased overall mortality (OM) and cancer specific mortality (CSM) compared to the 25%-50% quartiles and upper quartile BMI groups. Kaplan-Meier estimates showed similar results. Based on multivariate Cox regression analysis, preoperative BMI as a continuous variable was an independent predictor for OM and CSM. In conclusion, preoperative underweight patients with UTUC in Korea survive less after RNU. Preoperative BMI may provide additional prognostic information to establish risk factors.
INTRODUCTION
Upper tract urothelial carcinoma (UTUC) is a relatively rare neo plasm and accounts for 5%6% of all urothelial tumors. Approx imately 20%40% of patients initially present with locally advan ced disease and lymph node metastases at the time of diagno sis (14) . Radical nephroureterectomy (RNU) is the surgical stan dard of care for the treatment of patients with UTUC (5). How ever, contemporary oncologic outcomes remain poor because of the high risk of systemic recurrence following surgery (6) . The 5yr survival rates for patients classified with pT2 and pT3 stage disease are 73% and 40%, respectively, and the median survival for patients with T4 stage disease is estimated to be 6 months (7, 8) . Tumor stage, grade, lymph node status, lymphovascular in vasion (LVI), multifocality, and histologic tumor necrosis are pathological variables identified as prognostic factors in UTUC following RNU (9, 10) . More accurate predictors of clinical out comes could possibly lead to better identification and counsel ing for patients with potentially unfavorable outcomes who may benefit from adjuvant chemotherapy (1113). Currently, knowl edge of preoperatively assessable prognostic factors in UTUC is still limited. Preoperative prognostic factors including patients' body composition, age, gender, and previous bladder cancer history may offer the opportunity for more convenient stratifi cation prior to operation, compared to conventional pathologi cal risk factors (14) . The relationship among obesity, cancer risk, and prognostic influence of body mass index (BMI) have been reported for numerous malignancies (1517), but the impact of BMI on the prognosis of patients with UTUC is still poorly de fined. Previous studies revealed contradictory results regarding the prognostic value of BMI in patients with UTUC after RNU. Most studies on Western cohort have shown that higher BMI is associated with worse survival outcomes (18, 19) , whereas stud ies of Asian population noted that increased BMI was an inde pendent predictor for favorable survival (14, 20) . Asian popula tions have a higher percentage of body fat for a given BMI than Caucasians and the Asia Cohort Consortium proposed a new BMI cutoff for public health action in Asia (21) . Difference in body composition profiles and inclusion criteria between eth nic groups may explain these discrepancies. However, only two http://dx.doi.org/10.3346/jkms.2015. 30.10.1483 Asian population studies examining the effect of BMI on the oncological outcomes after RNU have thus far been reported and limited by its small sample size. Moreover, no study in Ko rea has been reported yet. Therefore, we investigated the prog nostic role of BMI in patients treated with RNU for UTUC from a large, multiinstitutional Korean collaboration.
MATERIALS AND METHODS

Patients
After obtaining institutional review board (IRB) approval, a da tabase of 505 patients with UTUC who underwent either open or laparoscopic RNU between 2001 and 2013 at four academic centers was reviewed. The database listed patient characteris tics including age, gender, BMI, history of bladder cancer, pre operative American Society of Anesthesiologists Physical Status (ASAPS) score, surgical approach (open vs. laparoscopic), tu mor pathology (stage, grade, lymph node status, and lympho vascular invasion), tumor necrosis, concomitant carcinoma in situ, tumor location, use of adjuvant chemotherapy, prior en doscopic therapy, unifocal or multifocal disease (UTUC multi focality was defined as the synchronous presence of multiple tumors in the renal pelvis or ureter), disease recurrence, mor tality from urothelial carcinoma. All of the patients had com plete followup data available and were considered for the anal ysis. A computerized databank was generated for the data trans fer. After combining the data sets, reports were generated for each variable to identify data inconsistencies and other data in tegrity problems. Prior to final analysis, the database was fro zen, and the final data set was produced for the current analy sis. To avoid biasing the survival estimates, patients who had previous or concomitant muscleinvasive bladder tumors treat ed by cystectomy were excluded. Patients with distant metasta sis at diagnosis and those who received neoadjuvant therapies were also excluded and 440 patients remained eligible.
Surgery was performed according to the standard criteria for RNU: extrafascial dissection of the kidney with the entire length of the ureter and the adjacent segment of the bladder cuff. The hilar and regional lymph nodes adjacent to the ipsilateral great vessel were generally resected if they were palpable intraopera tively or enlarged during preoperative axial imaging. All surgi cal specimens were processed according to the standard patho logical procedures at each institution. The tumor was assessed according to the 2002 American Joint Committee on Cancer/ Union Internationale Contre le Cancer TNM classification. Tu mor grading was assessed using the 1998 World Health Organi zation/International Society of Urologic Pathology consensus classification.
Each patient was monitored according to the standard guide lines. In general, patients were evaluated every 34 months for the 1st year following nephroureterectomy, every 6 months from the second through the 5th year, and annually thereafter. Fol lowup consisted of a history taking, physical examination, rou tine blood and serum chemistry laboratory work, urine cytolo gy, chest radiography, cystoscopic evaluation of the urinary bla dder, and radiographic evaluation of the upper urinary tract. Bone scans, chest computed tomography, or magnetic reso nance imaging was performed when clinically indicated.
In this study, disease recurrence was defined as a locoregion al recurrence or a new distant metastasis based on clinical and radiographic findings. Recurrencefree survival was defined as the period between surgery and the detection of recurrence, distant metastasis, or the study's endpoint. Time to cancerspe cific survival was calculated as the time from surgery to the date of cancerattributable mortality. . Continuous variables are shown as the median and interquartile range (IQR). Differenc es in variables with continuous distributions across dichoto mous categories were assessed using ANOVA. The Fisher's ex act and chisquare tests were used to evaluate the association between categorical variables. The statistical endpoints for our analysis were recurrencefree, cancerspecific, and overall sur vival of patients. Survival analyses were conducted according to the KaplanMeier method and survival characteristics were compared using the logrank test. Univariate and multivariate survival analyses were performed using the Cox proportional hazard regression model. Statistical significance was considered to be P < 0.05 and all reported P values are 2sided. Analyses were performed using SPSS 20.0 software (SPSS Inc., Chicago, IL, USA).
Statistical analysis
Ethics statement
The study was carried out in agreement with the applicable laws and regulations, good clinical practices, and ethical principles as described in the Declaration of Helsinki. The institutional re view board of Yonsei University College of Medicine approved this study protocol (Approval number: 420140634). Informed consent was waived by the board. Table 1 lists the demographics and clinicopathological charac teristics of the study population categorized by preoperative BMI quartiles. There were no significant differences among the subsets of patients in terms of clinicopathological characteris tics including age, gender, history of previous or concomitant bladder cancer, ASAPS score, pathologic stage, pathologic grade, lymph node status, lymphovascular invasion, surgical margin status, concomitant carcinoma in situ, tumor location, adjuvant chemotherapy, or multifocality (all P > 0.05).
RESULTS
Clinicopathological characteristics according to BMI categories
Locoregional recurrence/distant metastasis by BMI categories
The median followup period of the study cohort was 31 months (IQR 15 to 57 months). Overall, 111 patients (25.2%) experienc ed locoregional recurrence/distant metastasis. The recurrence/ metastatic free survival at 3 and 5 yr were 72% and 67%, respec tively. Compared to the lower quartile BMI group, the 25%50% quartiles was associated with approximately 50% reduced odds of locoregional recurrence/distant metastasis ( Table 2) . Kaplan Meier analyses did not exhibit significantly different recurrence free survival between BMI grouping (Figure not shown). Overall mortality and cancer specific mortality by BMI categories During follow up, 69 patients (15.7%) died of UTUC. The cancer specific survival (CSS) at 3 and 5 yr was 82% and 76%, respec tively. The 25%50% quartiles and upper quartile BMI groups were associated with approximately 60% reduced odds of over all mortality (OM) and cancer specific mortality (CSM) than the lower quartile BMI group following adjustment for pathologic T stage and pathologic grade ( Table 2 ). KaplanMeier estimates showed that the lower quartile BMI group had poorer overall survival (OS) and CSS compared to the middle two quartiles and the upper quartile BMI groups (Fig. 1) . Using multivariate Cox regression analysis, preoperative BMI as a continuous vari ables (HR, 0.922; CI, 0.8530.998, P = 0.045), ASAPS score (≥ 3) (P = 0.033), locally advanced stage or node positive state (P = 0.047), lymphovascular invasion (P < 0.001), and margin status (P = 0.008) were independent predictors of OM (Table 3) . On the other hand, preoperative BMI as a continuous variables (HR, 0.906; CI, 0.8300.990, P = 0.028), ASAPS score (≥ 3) (P = 0.025), locally advanced stage or node positive state (P = 0.027), lym phovascular invasion (P < 0.001), surgical margin (P = 0.010) were independent predictors of CSM (Table 4 ).
DISCUSSION
The current study investigated the prognostic role of BMI in a large, multiinstitutional cohort of patients treated with RNU for UTUC. We categorized the patients' cohorts into quartiles rather than using established BMI cutoff points, and demon strated that the preoperative BMI offers additional prognostic information.
Numerous studies have detected a significant association be tween preoperative BMI and cancersusceptibility or aggressive ness in several hormonerelated cancers, such as breast and en dometrial cancer (22, 23) . BMI strongly correlates with densi tometry estimates of body fat composition in adults, and excess body fat is associated with increased insulin, which increases in sulinlike growth factorI (IGFI). IGFI stimulates cell prolifera tion and suppresses apoptosis (24, 25) . Excess body fat is also as sociated with systemic inflammation. Adipose tissue produces a variety of inflammatory factors, including leptin, adiponectin, and cytokines (26, 27) . It is increasingly apparent that cancer progression depends on a complex interaction between the tu mor and host inflammatory responses. On the other hand, there is a paucity of data on the influences of BMI in hormoneinde pendent cancers such as urothelial carcinoma of the upper or lower urinary tract. There is no doubt that obesity strongly corre lates with perioperative complications and morbidity or mortal ity; however, little is known about the prognostic value of BMI in patients with UTUC after radical surgery (28) . Previous studies revealed contradictory prognostic outcomes associated with BMI in UTUC patients. Ehdaie et al. (18) showed that increased BMI adversely impacts oncological outcomes in pati ents with UTUC. They found a 37% difference in both 5yr diseasefree survival and CSS rates between patients with BMI ≥ 30 kg/m 2 (49%, 47%) and patients with BMI < 25 kg/m 2 (86%, 84%). They also found that patients with a higher body mass index were more likely to have infiltrative architecture and lymphovascular invasion. In our cohort, none of clinicopathologic variables shows interesting differences between BMI quartiles. Regard to locoregional recurrence/distant metastasis, the 25%50% quar tile group have an approximately 50% reduced odds of locore gional recurrence/distant metastasis compared to the lower quartile BMI group, however, there was no significant differenc es among other subsets of patients. Thus we could not sure the potential association between BMI and aggressive tumor char acteristics. A Canadian multicenter collaboration study reported that patients with higher BMI (BMI ≥ 30 kg/m 2 ) had worse RFS in patients undergoing RNU (1). However, they did not found any significant differences in OS or CSS among subsets of pa tients (BMI < 25, 25 ≤ BMI < 30, and BMI ≥ 30 kg/m 2 ). In con trast, using a cohort of 103 Japanese UTUC patients, Inamoto et al. (14) employed original BMI cutoff (22 kg/m 2 ) and showed that increased BMI (BMI ≥ 22 kg/m 2 ) was an independent pre dictor for favorable OS and CSS. More recently, Liu et al. (20) an alyzed single center data for 236 Chinese UTUC patients. In this study, the mean CSS time was 42.7 months for underweight pa tients, 55.1 months for normal patients and 61.2 months for obe sity patients. They also demonstrated that a preoperative under weight was an independent predictor of unfavorable survival in patients with UTUC. They postulated three hypotheses to explain the improved outcomes for obese patients, including a functional barrier, increased energy sources, and multiple hormonal, en docrine, or nutritional factors. Although our data was similar to previous Asian cohort studies, it is hard to direct comparison of prognostic influence of BMI among stu dies because we did not use the established BMI criteria for Asi ans, issued by the Asia Co hort Consortium. Because there were only 16 patients (4% of to tal cohort) with underweight defined by Asia Cohort Consor tium (BMI lower than 18.5 kg/m 2 ) in our cohort, we categorized the patients into approximate quartiles instead of using estab lished BMI cutoff points. By the definition of the Asia Cohort Consortium, preoperative underweight may overlap with tumor cachexia (29) . Tumor cachexia has long been postulated to be a (30) . In our preliminary analyses, op timal BMI cutoff value which gave optimal sensitivity and speci ficity for cancer specific mortality in patients treated with RNU for UTUC was 21.61 kg/m 2 (data not shown). To determine the opti mal BMI cutoff point can stratify patients with UTUC after RNU into unfavorable or favorable prognostic groups, additional col laboration studies in other populations are inevitable.
Our study had several inherent weaknesses. First, standard ization of surgical techniques or practice guidelines such as ad juvant chemotherapy and followup protocols was impossible because of the multiinstitutional and retrospective nature of the study. Relatively short periods of followup and its retrospec tive nature also warrant consideration. In addition, databank from four institutions did not handle the weight change. Weight loss has been shown to be an independent prognostic indicator of decreased survival in cancer patients. However, our study co hort has a relatively localized stage and metastatic cancer pati ents with severe cachexia were excluded.
In conclusion, preoperative underweight patients with UTUC in Korea survive less after RNU. Current high volume, multi center study reconfirmed the adverse prognostic impact of pre operative underweight in Korean UTUC patients following RNU. International collaboration studies are needed to give an account for ethical contradictory results between Asia and the West.
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